These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24126833)

  • 21. Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients.
    Helwig U; Müller M; Hedderich J; Schreiber S
    J Crohns Colitis; 2012 May; 6(4):419-24. PubMed ID: 22398067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.
    Kim KH; Lee SW; Chung WT; Kim BG; Woo KS; Han JY; Kim JM
    Korean J Lab Med; 2011 Oct; 31(4):271-8. PubMed ID: 22016681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of Interferon-Gamma Release Assays for Tuberculosis Screening in Pediatric Inflammatory Bowel Disease.
    Stevens JP; Ballengee CR; Chandradevan R; Thompson AB; Schoen BT; Kugathasan S; Sauer CG
    J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):e111-e116. PubMed ID: 31261245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indeterminate results of QuantiFERON-TB Gold In-Tube assay in nonimmunosuppressed children.
    Zrinski Topić R; Zoričić-Letoja I; Pavić I; Dodig S
    Arch Med Res; 2011 Feb; 42(2):138-43. PubMed ID: 21565627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
    Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
    Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
    J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection.
    Critselis E; Amanatidou V; Syridou G; Spyridis NP; Mavrikou M; Papadopoulos NG; Tsolia MN
    J Pediatr; 2012 Oct; 161(4):632-8. PubMed ID: 22632878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.
    Lucas M; Nicol P; McKinnon E; Whidborne R; Lucas A; Thambiran A; Burgner D; Waring J; French M
    Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study.
    Song DJ; Tong JL; Peng JC; Cai CW; Xu XT; Zhu MM; Ran ZH; Zheng Q
    J Dig Dis; 2017 Jan; 18(1):23-30. PubMed ID: 28009090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?
    González-Moreno J; García-Gasalla M; Losada-López I; Cifuentes Luna C; Mir Viladrich I; Fernández-Baca V; Serrano A; Juan Mas A; Riera-Oliver J; Payeras Cifre A
    Rheumatol Int; 2018 Feb; 38(2):267-273. PubMed ID: 29051973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis].
    Komukai J; Matsumoto K; Tomihara A; Miyake Y; Tatsumi T; Arima K; Danno K; Hirota S; Yoshida H; Koda S; Terakawa K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):847-56. PubMed ID: 22250463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Novacek G; Vogelsang H; Dejaco C; Reinisch W
    Inflamm Bowel Dis; 2011 Jan; 17(1):84-90. PubMed ID: 20722065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.